Apoha
AI-enabled molecular science / deep technology
Liquid-state molecular measurement and AI for pharmaceutical, biotechnology, food, and materials R&D
Series A
Apoha Limited is a London- and San Francisco–based deep-technology company developing “Liquid State Intelligence”: proprietary instrumentation, laboratory workflows, and AI models that measure molecular behaviour at engineered liquid interfaces. Its first commercial platform, VIBE, is positioned as a new data source for R&D across pharmaceuticals/biologics, biotechnology, food, and materials. In healthcare-related applications, Apoha is focused on molecular and drug-development research rather than clinical care delivery; it states that its data can help assess properties of drug candidates and formulations earlier in development.
Company Details
- Website
- apoha.com
- Headquarters
- London, United Kingdom; operations also in San Francisco, United States
- Founded
- 2021
- Funding
- $36M cumulative (including a 2024 seed round and a further unlettered round completed in spring 2026
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring